ARCHIVES

In Brief: Recompetition Of Frederick Contract Flops, As Others Leave The Field To Litton-Bionetics

This article is from The Cancer Letter archive.

Vol. 03 No. 15 | April 15, 1977

Download PDF Visit The Full Archive

Related Articles

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

September 13, 2002

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

September 25, 1998

HHS Inspector General: Busy Signals Greet One In Three Callers To 800-4-CANCER

July 24, 1998

CIS Recompetition Approved, But BSC Delays Decision On Matching Requirement

May 15, 1987

ASCO, FDA Website To Help Demystify Expanded Access

June 25, 2010

In Brief: Albert and Mary Lasker Foundation announce 2014 award winners

September 12, 2014